Sema4 to Participate at Two Investor Conferences in June 2022

Rhea-AI Summary

Sema4 (Nasdaq: SMFR) announced participation in two upcoming investor conferences. The Jefferies Healthcare Conference will feature a fireside chat on June 9, 2022, at 8:30 a.m. ET. Following this, they will attend the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022, at 12:20 p.m. ET. Live and archived webcasts will be accessible on their investor relations website. Sema4, a health intelligence company, utilizes AI for genomic and clinical data insights, aiming to enhance patient care through individualized health solutions.

STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor conferences:

• Conference: Jefferies Healthcare Conference 
  Format: Fireside chat and 1x1s 
  Presentation Date/Time: Thursday, June 9^th, 2022 at 8:30 a.m. ET

• Conference: Goldman Sachs 43^rd Annual Global Healthcare Conference 
  Format: Fireside chat and 1x1s 
  Presentation Date/Time: Thursday, June 16^th, 2022 at 12:20 p.m. ET / 9:20 a.m. PT

Live and archived webcasts of the presentations will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com 

Media Contact:
Radley Moss
Sema4
radley.moss@sema4.com 

FAQ

What dates will Sema4 present at the Jefferies Healthcare Conference?

Sema4 will present at the Jefferies Healthcare Conference on June 9, 2022, at 8:30 a.m. ET.

When is Sema4 participating in the Goldman Sachs Healthcare Conference?

Sema4 will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022, at 12:20 p.m. ET.

Where can I watch the Sema4 investor conference presentations?

Live and archived webcasts of Sema4's presentations will be available on their investor relations website.

What is the focus of Sema4's health intelligence platform?

Sema4's health intelligence platform focuses on using AI and machine learning to analyze genomic and clinical data to improve healthcare outcomes.

What stock symbol does Sema4 trade under?

Sema4 trades under the stock symbols SMFR and SMFRW.